Subject Index. Café-au-lait spots (CALS), 304 Candidal vulvovaginitis, 127. Clinics in Dermatology (2006) 24, e1 e11

Transcription

1 Clinics in Dermatology (2006) 24, e1 e11 Acanthosis nigricans, , 293 treatment of, 241, Acne, 115, 123 ALA PDT for, 23 laser-mediated (PDT) for, laser therapy for, diode laser, Er:glass laser, 30 potassium titanyl phosphate laser, 28 pulsed dye laser, LP PDL-mediated for, 21 pathogenesis, photodynamic therapy 5-aminolevulinic acid (ALA), 30 indocyanine green, Acne for dummies (HP Goodheart) (ed. Mark Lebwohl, MD) (book review), 535 Acne vulgaris, laser-mediated PDT for treatment of, 16 treatment of, 296 Acrochordons (skin tags), 241 Acrodermatitis enteropathica, 90 Acromegaly, skin manifestations in, , noncutaneous clinical presentation, Acropustulosis, infantile, in tropics, 161 Actinomycetomas, 206 Acute febrile dermatosis (Sweet s syndrome), Addison s disease, clinical presentation, of, diagnosis of, 279 management of, Adrenocorticotropic hormone (ACTH), 267 African histoplasmosis, Airborne contact dermatitis, in tropics, 161 Alefacept, for psoriasis and psoriatic arthritis, 442 Alexandrite laser. See also Laser(s) Q-switched, Allergy, in tropics lichen planus, lichen planus actinicus, 164 urticaria, 164 Androgenic alopecia, treatment of, 297 Androgen-related disorders, dermatology of. See Hyperandrogenism Anetoderma classification of, 93 and pregnancy, Angiotensin-converting enzyme (ACE) inhibitors, for systemic sclerosis, 388 Aphthosis, 125 Argyria, Atopic dermatitis, in tropics, Austrian Dermatologic Society, award of the Gold Medal for, Autoimmune progesterone dermatitis, 120 Axilla, Fox-fordyce disease of, 116 Bacterial vaginosis, Behçet s disease, 125, Bejel (endemic syphilis), Benign chronic bullous dermatosis of childhood, in tropics, 163 Besnier prurigo, Bibliography of secondary sources on the history of dermatology journal articles in English, obituaries and biographies in English before 1973, Book reviews Acne for dummies (HP Goodheart) (ed. Mark Lebwohl, MD), 535 Fifty cases in dermatological medicine (D Creamer and A du Vivier), 72 Procedures in Cosmetic Dermatology Series: Photodynamic Therapy (MP Goldman), Bosentan, for systemic sclerosis, 388 Bowel-associated dermatosis-arthritis syndrome, Bronchospasm, and carcinoid tumors, 309 Café-au-lait spots (CALS), 304 Candidal vulvovaginitis, X/$ see front matter doi: /s x(06)

2 e2 Canine endocrine dermatoses, dermatology of canine hyperadrenocorticism, 320 clinical presentation, 320, diagnosis of, treatment of, 322 canine hypothyroidism, clinical presentation, 318, diagnosis of, treatment, 320 sex hormone dermatoses, 322 hyperandrogenism, 323 hyperestrogenism, Canine hyperadrenocorticism, 320 clinical presentation, 320, diagnosis of, treatment of, 322 Canine hypothyroidism, clinical presentation, 318, diagnosis of, treatment, 320 Carcinoid tumors, 309 clinical presentation bronchospasm, 309 cardiac valvular lesions, 309 diarrhea, 309 others, mastocytomas, 310 urticaria pigmentosa (UP), 310 diagnosis, management of, 311 Cardiac valvular lesions, and carcinoid tumors, 309 Carney complex, 308 clinical presentation, 308, diagnosis and management, 309 Children, of tropics, benign chronic bullous dermatosis in, 163 Chloasma, 134 Chlorambucil, for systemic sclerosis, 387 Chromoblastomycosis (chromomycosis), Connective tissue diseases, and pregnancy anetoderma, Ehlers-Danlos syndrome, pseudoxanthoma elasticum, Contact dermatitis, in tropics, 161 Cosmetic Dermatology, procedures in, Photodynamic Therapy (MP Goldman) (book review), Cosmetics preservation: sense and nonsense, Cryptococcosis, Cushing s syndrome clinical presentation, , diabetes/hyperglycemia and, diagnosis of dexamethasone 1 mg (overnight) suppression test, 263 late night salivary cortisol, therapy, twenty-four-hour urine cortisol, 263 effect on reproductive system, 262 hypertension and cardiovascular disease and, 263 infections in, 263 muscle atrophy/weakness in, 262 obesity and, 262 psychiatric symptoms, 262 skeletal effects, 262 thrombotic events in, 263 Cutaneous vasculitis, diagnosis and management, classification, clinical pathologic correlation, 418 diagnosis, epidemiology, pathogenesis, therapy, Cyclophosphamide, for systemic sclerosis, 387 Cyclosporine, topical, for Sjfgren s syndrome treatment, 406 Cystic chromoblastomycosis, 207 Dermal remodeling, nonablative, and photothermal ablation, 5-6 Dermatitis herpetiformis, in tropics, 163 Dermatological medicine (D Creamer and A du Vivier) (book review), 72 Dermatologic disquisitions and other essays Living with a skin condition, Why not Nichols chemosurgery?, Dermatologist of distinction Juan Di Prisco, MD ( ), Maurizio Binazzi, Dermatologists, Eugene M. Farber, MD ( ), Hulusi Behçet ( ), Dermatology endocrinology in, and lasers, 1 and rheumatology: part 2, 347, 469 tropical, 151 Dermatology, cosmetic, procedures in, (MP Goldman) (book review), Dermatomyositis (DM), 363 classification and clinical appearance classification, 364, drug-induced DM, 368 juvenile (childhood) DM, 368 muscle disease, 367

3 Dermatomyositis (DM) (continued) classification and clinical appearance (continued) myositis and malignancy, systemic features, 367 diagnosis and evaluation of the patient with, additional therapeutic options, 369 corticosteroids and immunosuppressive agents, 369 course and therapy, 369 management of cutaneous disease with, prognosis, 370 Dermatophytosis, in tropics Tinea capitis, 203 Tinea corporis, Tinea imbricata, 203 Tinea nigra, 203 Tinea pedis, 202 Dermatoses associated with pregnancy, of pregnancy, sex hormone, and tumors affected by pregnancy aphthosis, 125 atopic dermatitis, 126 Behçet s disease, 125 pemphigus vulgaris, pustular psoriasis/impetigo herpetiformis, 125 pyogenic granuloma, Dermatoses, neutrophilic, acute febrile dermatosis (Sweet s syndrome), Behçet s disease, bowel-associated dermatosis-arthritis syndrome, neutrophilic eccrine hidradenitis, pustular psoriasis, 476 acrodermatitis continua and palmoplantar pustulosis, subcorneal pustular dermatosis (Sneddon-Wilkinson disease), pyoderma gangrenosum, synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome, 476 Diabetes mellitus, 237 clinical presentation of, acanthosis nigricans, acrochordons (skin tags), 241 diabetic bullae, 241 diabetic dermopathy (ddshin spotstt), 239 granuloma annulare, 240 necrobiosis lipoidica, 239 scleredema (scleredema adultorum of Buschke), 240 yellow skin (carotenodermia), 240 dermatologic complications of the treatment of complications of continuous subcutaneous insulin infusion, 243 immunologic reactions to insulin, 243 Diabetes mellitus (continued) dermatologic complications of the treatment of (continued) reactions to oral antidiabetic agents, 243 diagnostic criteria, 238 noninfectious skin disorders, treatment of acanthosis nigricans, 241 granuloma annulare, 241 necrobiosis lipoidica, 241 scleredema, 241 skin infections and, erythrasma, 242 malignant external otitis, 242 necrotizing fasciitis, 242 rhinocerebral mucormycosis, skin infections treatment in erythrasma, 243 external otitis media, 243 mucormycosis, 243 necrotizing fasciitis, 243 Diabetic bullae, 241 Diabetic dermopathy (ddshin spotstt), 239 Diarrhea, and carcinoid tumors, 309 D-penicillamine, for systemic sclerosis, 388 Drug eruptions, in tropics erythema multiforme, 165 erythema nodosum, 166 fixed, toxic epidermal necrolysis, Drugs, for systemic sclerosis to inhibit fibrosis D-penicillamine, 388 gamma interferons, 387 interferon-a, 388 relaxin, 388 to prevent vascular damage angiotensin-converting enzyme inhibitors, 388 bosentan, 388 prostacyclin analogues, 388 sildenafil, 388 suppression of autoimmunity and inflammation chlorambucil, 387 cyclophosphamide, 3875-Fluorouracil, 387 methotrexate, 387 stem cell transplantation, 387 Dyshidrosis. See Pompholyx Early-onset prurigo of pregnancy (EOPP), 119 Eczematous dermatitis, and related conditions in tropics airborne contact dermatitis, 161 atopic dermatitis, contact dermatitis, 161 infantile acropustulosis, 161 papular urticaria, pompholyx, 160 Efalizumab, for psoriasis and psoriatic arthritis, e3

4 e4 Ehlers-Danlos syndrome classification of, 94 and pregnancy, Endemic treponematosis, bejel (endemic syphilis), pinta, yaws, Endocrinology, in dermatology, Erythema migrans, 509 case history, clinical presentation of, deer tick bites, 512 differential diagnosis of, 513 history of, 511 laboratory diagnosis of, 513 prognosis of, treatment of, 513 Erythema multiforme, Erythrasma and diabetes mellitus, 242 treatment, 243 Etanercept, for psoriasis and psoriatic arthritis, External otitis and diabetes mellitus malignant, 242 treatment, Fluorouracil, for systemic sclerosis, 387 Follicle stimulating hormone (FSH), 268 Fox-fordyce disease of axilla, 116 Fungal infections, Gamma interferons, for systemic sclerosis, 387 Gender-Specific Medicine, First World Congress on, Glucagonoma and necrolytic migratory erythema, 300 clinical presentation, 300, diagnosis abdominal computed tomographic scan, 301 biopsy, endoscopic ultrasonography, 301 imaging modalities, 301 serum glucagon, 301 management other modalities, 302 resection, 302 Gout attack prophylaxis, 504 clinical features, dermatologic manifestations, 502 epidemiology, hypouricemic therapy, pathophysiology, 499 role of imaging modalities in diagnosis, 503 treatment, Granuloma annulare, 240 treatment of, 241 Graves disease. See Hyperthyroidism Griseofulvin, for dermatophytosis, 203 Growth hormone (GH), 268 Hair, changes during pregnancy, 81 HDCT. See Hereditary disorders of connective tissues Hebra prurigo, 119 Hemangiomas, 12 Hematoporphyrin, for treatment of tumors, 16 Hendersonula toruloidea. See Scytalidium infections Hereditary disorders of connective tissues (HDCTs) clinical spectrum in hypermobility, 523 joint and bone pathology, marfanoid habitus, nonmusculoskeletal pathology, ocular pathology, 529 skin disorders, genetic abnormalities in, protein synthesis and, 522 Herpes gestationis (HG), 86, Herpes simplex virus (HSV), Hidradenitis suppurativa, 115 Hirsutism, 135, central facial/mustache distribution of, treatment of, 296 HIV. See Human immunodeficiency virus HIV/AIDS patients infections caused by Cryptococcus neoformans, 208 systemic fungal infections, 202 HIV infection and atopic eczema, 160 coinfection with scrub typhus, in tropical rickettsioses, 197 and photodermatitis, 161 Human immunodeficiency virus (HIV), 536 mother-to-child HIV transmission (MTCT) and risk factors diagnosis of HIV in pregnancy, 537 maternal factors, 537 neonatal factors, 537 obstetrical factors, 537 prevention of MTCT of HIV breast-feeding interventions, 538 issue of resistance to ARVT, 540 mode of delivery, 538 use of ARVT in pregnancy, Human leukocyte antigen, (HLA)-G in skin diseases, 85 Human papillomavirus, 128 Hyperandrogenism, clinical presentation, acanthosis nigricans, 293 acne vulgaris, androgenic alopecia, hirsutism, seborrhea, 294 diagnosis of, 294 in dogs, 323 in infants and children, 290

5 Hyperandrogenism (continued) treatment of, acanthosis nigricans, androgenic alopecia, 297 hirsutism and acne, 296 Hyperestrogenism, in dogs, Hyperparathyroidism clinical presentation, metastatic calcification, Multiple endocrine neoplasia 2a (MEN 2a), Multiple endocrine neoplasia 1 (MEN1), 283 sporadic hyperparathyroidism, 283 diagnosis of, 285 management, 285 Hyperplasia, sebaceous, laser-mediated PDT for treatment of, 16 Hyperthyroidism, clinical presentation and, diagnosis of, 249 treatment, 249 Hypoparathyroidism clinical presentation, , 287 diagnosis, 287 treatment, 287 Hypopituitarism, causes of, 269 dermatologic manifestations of body morphology, eccrine and sebaceous glands, 272 hair, skin pigmentation, skin texture, 271 diagnosis of, 273 diseases associated with both dermatologic manifestations and, 273 functional anatomy of the pituitary gland, management of, nondermatologic manifestations of, pituitary hormones adrenocorticotropic hormone (ACTH), 267 follicle stimulating hormone (FSH), 268 growth hormone (GH), 268 luteinizing hormone (LH), 268 oxytocin (OT), 269 prolactin (PRL), 268 thyroid-stimulating hormone (TSH), vasopressin, Hypothyroidism, clinical presentation and, diagnosis and treatment, Hypouricemic therapy, Impetigo herpetiformis, , 125 Infantile acropustulosis, in tropics, 161 Infections Cushing s syndrome in, 263 fungal, Intense pulsed light (IPL). See Photodynamic therapy Interferon-a, for systemic sclerosis, 388 International Academy of Cosmetic Dermatology, IV World Congress of, Itch and scratch: scabies and pediculosis, Joint hypermobility and skin elasticity. See Hereditary disorders of connective tissues Juvenile dermatitis herpetiformis. See Benign chronic bullous dermatosis KTP laser. See Potassium titanyl phosphate laser Laser light, properties of, 2 Laser-mediated photodynamic therapy, Laser operation clinical practice guidelines, legal issues in, Laser(s) continuous and quasi-continuous wave, 8-9 and dermatology, 1308-nm excimer, for treatment of psoriasis and vitiligo, medical, boff-label Q uses of, potassium titanyl phosphate, 10 pulsed dye (PDL), 9-10 red and IR, treatment of vascular lesions, 8-14 LASER-tissue interactions, 2-7 LE. See Lupus erythematosus Lichen planus, allergic condition in tropics, Lichen sclerosus, laser-mediated PDT for treatment of, 21 Linear IgM dermatosis (LID), of pregnancy, Lipoatrophy, 243 Lipohypertrophy, 243 Lisch nodules, and neurofibromatosis type 1, 303 Lobomycosis, 208 Localized scleroderma (morphea), classification and clinical presentation bullous (vesicular) morphea, 376 deep morphea, linear morphea, 376 plaque morphea, diagnosis, epidemiology, 375 etiology and pathogenesis, 375 prognosis and treatment, Loxosceles, Loxoscelism, e5

6 e6 Lupus erythematosus (LE), systemic and cutaneous manifestations, 348 acute cutaneous LE, chronic cutaneous LE, clinical characteristics, 349 pathophysiology, 349 subacute cutaneous LE (SCLE), immunopathology/lupus band test, 354 laboratory findings autoantibodies, 356 complement proteins, 356 precipitating factors, 356 musculoskeletal manifestations, nonspecific skin disease, other clinical manifestations, cardiovascular manifestations, 355 gastrointestinal manifestations, 355 menstrual abnormalities and pregnancy, 356 parotid gland enlargement and Sjfgren s syndrome, 355 psychologic problems, 355 treatment,, 357 antimalarials, local calcineurin inhibitors, 358 local corticosteroids, 358 other systemic antiinflammatory agents, 359 recombinant biologic response modifiers, 360 ultraviolet-a1 phototherapy, UV light protection, treatment, systemic manifestations conventional agents, experimental agents, 357 Luteinizing hormone (LH), 268 Lyme arthritis, 515 non-em dermatologic manifestations of, 514 persistent (longer than a year), Lymphangioma, 10 Madura foot. See Maduromycosis Maduromycosis, Malassezia increased incidence of, 202 infections, 204 Malnutrition, skin disorders in, Mastocytomas, 310 Mastocytosis, 311 clinical presentation gastrointestinal, 311 hematologic abnormality, 312 lymphoid tissue and spleen, 311 neurologic manifestations, 312 skeletal scintigraphy, 312 diffuse CM, 312 erythrodermic mastocytosis, 312 mastocytomas, 310 Mastocytosis (continued) (continued) pseudoxanthomatous mastocytosis (xanthelasoidea), 312 telangiectasia macularis eruptive perstans, 312 urticaria pigmentosa (UP), 312 Mastocytosis diagnosis, management, 313 cutaneous mastocytosis, 313 systemic mastocytosis, 313 Maurizio Binazzi, dermatologist of distinction, McCune-Albright syndrome clinical presentation, 305, 305 diagnosis, 305 management of, Medical espionage, physician-authored: who and why, Medical lasers, boff-labelq uses of, Melasma perioral hypermelanosis of, 123 pigmentary change in pregnancy, Metabolic diseases and pregnancy, Metabolic diseases: gout, Methotrexate, for systemic sclerosis, 387 Microsporum audouinii, casuative agent of Tinea capitis, 203 Mites. See Scabies Morphea. See Localized scleroderma MRH. See Multicentric reticulohistiocytosis Mucormycosis and diabetes mellitus, treatment, 243 Multicentric reticulohistiocytosis (MRH) articular features, 488 associated diseases, clinical manifestations, 487 cutaneous features, diagnosis, 490 differential diagnosis, electron microscopy, 490 epidemiology/demographic features, 487 etiology, 487 histochemical studies, 490 histopathological features, historical perspective and definition, immunohistochemistry, 490 laboratory findings, 489 mucosal features, 488 other manifestations, 488 pathogenesis, 487 radiographic features, 490 treatment and prognosis, 491 Multiple endocrine neoplasia (MEN), 306 clinical presentation medullary thyroid cancer, 306 pancreatic islet cell tumors, 307

7 Multiple endocrine neoplasia (MEN) (continued) clinical presentation (continued) pheochromocytoma, pituitary adenomas, 307 primary hyperparathyroidism, 307, 307 diagnosis, management, 308 Mycetoma, agents and grains, 205 Mycoses classification of, 202 subcutaneous chromoblastomycosis (chromomycosis), lobomycosis, 208 mycetoma (maduromycosis, Madura foot), phaeohyphomycosis (phaeomycotic cyst, cystic chromoblastomycosis), 207 sporotrichosis, zygomycosis, systemic African histoplasmosis, cryptococcosis, skin manifestations of, 209 tropical superficial dermatophytosis, Malassezia infections, 202, 204 Nail, changes during pregnancy, 81 Nd:YAG laser. See also Laser(s) Q-switched, 48 Necrobiosis lipoidica, 239 treatment of, 241 Necrotizing fasciitis and diabetes mellitus, 242 treatment, 243 Neurofibromatosis type 1, 302 clinical presentation hypertension, lisch nodules, 303 neurologic abnormalities, 303 peripheral neurofibromas, tumors, 303 Café-au-lait spots, 304 cutaneous neurofibromas, 304 cutaneous pigmentation, 304 freckling, 304 diagnosis, 304 management, Neutrophilic dermatoses, acute febrile dermatosis (Sweet s syndrome), Behçet s disease, bowel-associated dermatosis-arthritis syndrome, Neutrophilic dermatoses (continued) neutrophilic eccrine hidradenitis, pustular psoriasis, 476 acrodermatitis continua and palmoplantar pustulosis, subcorneal pustular dermatosis (Sneddon-Wilkinson disease), pyoderma gangrenosum, synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome, 476 Nurse s early prurigo of pregnancy, 119 Obesity, and Cushing s syndrome, 262 Onchocerciasis-river blindness, Oxytocin (OT), 269 Papular dermatitis of pregnancy (PDP), 119 Papular urticaria, in tropics, Parathyroid-related disorders, dermatologic manifestations of, hyperparathyroidism clinical presentation, , diagnosis of, 285 management, 285 hypoparathyroidism clinical presentation, , 287 diagnosis, 287 treatment, 287 Pediculosis, Pemphigoid gestationis. See Herpes gestationis Pemphigus foliaceus and erythematosus, in tropics, Pemphigus vulgaris, Penicillium marneffei infections, 202, Phaeoanellomyces werneckii, casuative agent of Tinea nigra, 203 Phaeohyphomycosis, 207 Photoallergic dermatitis and phytophotodermatitis, in tropics, 161 Photodynamic therapy (PDT), laser-mediated, acne, treatment of, 16, actinic cheilitis, treatment of, 19 actinic keratosis, treatment of, 195-aminolevulinic acid (ALA), cutaneous, light source for, 18 intense pulsed light (IPL)-mediated ALA PDT for actinic keratosis, lichen sclerosus, for treatment of, 21 long-pulsed pulsed dye laser (LP PDL)-mediated, red and blue lasers in, 18 for vascular lesions, 14 Photodynamic therapy (PDT) (MP Goldman) (book review), Photorejuvenation, 23 e7

8 e8 Photosensitizers, for treatment of tumors, 16 Photothermolysis, selective, 4 Pigmentation changes during pregnancy, disorders, therapeutic advances, 62 Pinta, endemic treponematosis, Pituitary gland adrenocorticotropic hormone (ACTH), 267 follicle stimulating hormone (FSH), 268 functional anatomy of, growth hormone (GH), 268 luteinizing hormone (LH), 268 oxytocin (OT), 269 Pituitary gland prolactin (PRL), 268 thyroid-stimulating hormone (TSH), vasopressin, Podoconiosis, in tropics, 161 Polymorphic eruption of pregnancy (PEP), 119 Pompholyx, in tropics, 160 Porphyria cutanea tarda, Porphyrins, 27 Port-wine stain, 12 Pregnancy cosmetic aspects of connective tissue changes in, hormonal changes in, 133 pigmentary changes in, the pilosebaceous unit, vascular changes, cosmetic procedures during, dermatoses of, autoimmune progesterone dermatitis, 120 Besnier prurigo, linear IgM dermatosis (LID) of, papular dermatitis of pregnancy (PDP), 119 polymorphic eruption of pregnancy (PEP), 119 Prurigo, prurigo annularis, 120 pruritic folliculitis (PFP) of, 120 Spangler s papular dermatitis of, 119 effects on oral cavity acne, 123 hirsutism, melasma, 123 pregnancy gingivitis, immunological aspects of, and metabolic diseases, miscellaneous diseases affected by, oral and vulvar changes in, and oral mucosa, 139 physiological and biological skin changes in, polymorphic eruption of, and the skin, and sweat glands, 137 Pregnancy (continued) vaginal and vulvar physiology of, varicose and spider veins, secondary to, 138 bthe mask of pregnancy,q 134 Pregnancy gingivitis, Price s disease. See Podoconiosis Prolactin (PRL), 268 Prostacyclin analogues, for systemic sclerosis, 388 Prurigo annularis, 120 Prurigo gestationis of Besnier, Prurigo of pregnancy, Pruritic folliculitis of pregnancy (PFP), 120 Pruritic urticarial papules and plaques of pregnancy (PUPPP), Pseudoxanthoma elasticum, Psoriasis, 86, 438 clinical features, 439 effect of pregnancy upon, 113 effects of T cells and the role of cytokines, 440 genetics of, 439 immunopathogenesis of, targeted therapy alefacept, 442 cytokine antagonism, efalizumab, etanercept, T-cell activation in, 440 T cells migration, 440 treated with topical corticosteroids, tachyphylaxis to, treatment of, 442 and vitiligo, 308-nm excimer laser for, Psoriasis vulgaris, treatment by 308-nm excimer laser, Psoriatic arthritis (PsA) clinical features, genetics of, 441 pathophysiology of, targeted therapy alefacept, 442 cytokine antagonism, efalizumab, etanercept, treatment of, 442 Pulsed dye lasers (PDL), 9-10 Pustular psoriasis, 125 Pyogenic granuloma, , 139 Q-switched ruby laser, 47 Raynaud s phenomenon, in systemic sclerosis, treatment of, Relapsing polychondritis (RP) clinical features, course and therapy, 485

9 Relapsing polychondritis (RP) (continued) differential diagnosis, pathogenesis, 484 Relaxin, for systemic sclerosis, 388 Rheumatoid arthritis, dermatologic manifestations of adult-onset Still s disease, 432 pyoderma gangrenosum (PG), Raynaud phenomenon, 431 rheumatoid neutrophilic dermatosis (RND), 433 rheumatoid nodules, 431 rheumatoid vasculitis, treatment of, 433 TNF-a inhibitors, Rheumatology and dermatology: part 1, 347 and dermatology: part 2, 469 Rhinocerebral mucormycosis and diabetes mellitus, Rickettsioses, tropical flea-borne murine typhus, louse-borne, management of, rickettsialpox, 194 scrub typhus, coinfection with HIV, 197 spotted fever group flea-borne, 194 tick-borne, River blindness. See Onchocerciasis Ruby laser, Q-switched, 47 Sarcoptes scabiei var humanus, mite causing scabies, 169 Scabies, Scleredema (scleredema adultorum of Buschke), 240 treatment of, 241 Scleroderma localized scleroderma (morphea), systemic. See Systemic sclerosis Scleromyxedema clinical, epidemiology, 493 histology, 494 pathophysiology, prognosis, 496 Scytalidium infections, Secretagogues, for Sjfgren s syndrome treatment, 407 Sex hormone dermatoses, Sildenafil, for systemic sclerosis, 388 Sjfgren s syndrome (SS), background, 394 cutaneous symptoms and signs in patients with, diagnostic criteria for, differential diagnosis, 404 lupus erythematosus and, 355 ocular symptoms and signs in patients with, 398 oral symptoms and signs in patients with, e9 Sjfgren s syndrome (SS), (continued) overview of pathogenesis and correlation with clinical symptoms, pitfalls in diagnosis and methodology, 396 systemic findings in patients with, treatment artificial lubricants, 405 Blepharitis management, 406 cutaneous therapy, ocular therapy, 405 oral therapy, punctal occlusion, secretagogues, 407 systemic therapy for extraglandular manifestations of, topical cyclosporine, 406 topical tacrolimus, 406 Skin cancer, changes, physiological and biological, in pregnancy, diseases, HLA-G in, 85 disorders, in malnutrition, and pregnancy, Smallpox in Bangladesh, 155 as biological weapon, in Birmingham, 156 in Europe, 154 final eradication, 156 history of, vaccination, variola minor, 155 the WHO global smallpox eradication program, 155 Spangler s papular dermatitis of pregnancy, 119 Spider hemangiomas, 138 Spiders. See also Loxosceles causing dermonecrosis, 215 Sporotrichosis, SSc. See Systemic sclerosis Stem cell transplantation, for systemic sclerosis, 387 Stevens-Johnson syndrome, 159 Striae gravidarum, 97-99, 136 Subacute cutaneous LE (SCLE), Sunscreens, reduction in efficacy of, Sweet s syndrome. See Acute febrile dermatosis Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome, 476 Syphilis, endemic. See Bejel Systemic sclerosis (SSc) clinical features, 381 diagnosis, differential, organ system involvement cutaneous involvement, 381 gastrointestinal tract, 382

10 e10 Systemic sclerosis (SSc) (continued) genitourinary, head and neck involvement, 384 heart, 383 kidney, 383 lung involvement, 383 musculoskeletal system, 382 nervous system involvement, 384 Raynaud s phenomenon, pathogenesis, treatment of individual organ system complications calcinosis, 387 gastrointestinal tract, 386 heart, 386 kidney, 386 lung, 386 musculoskeletal, 387 Raynaud s phenomenon, skin ulcerations, 387 treatment with disease-modifying drugs agents to inhibit fibrosis, to prevent vascular damage, 388 suppression of autoimmunity and inflammation, 387 Tachyphylaxis, to psoriasis patients treated with topical corticosteroids, Tacrolimus, topical, for Sjfgren s syndrome, 406 Tattoos, laser treatment of, Telangiectasia associated with pregnancy, 134 facial, Telogen effluvium, 136 Terbinafine, for dermatophytosis, 203 Thiamin deficiency, mechanism of skin lesions in, 226 Thyroid cancer, Thyroid disorders, dermatologic aspects of, 247 hyperthyroidism, clinical presentation and, diagnosis of, 249 treatment, 249 hypothyroidism, clinical presentation and, diagnosis and treatment, thyroid cancer, Thyroid-stimulating hormone (TSH), TNF-a inhibitors, drug-induced lupus, 434 leukocytoclastic vasculitis, 434 psoriasiform eruptions, 434 skin infections, 434 Toxic epidermal necrolysis (TEN), 159 Treponematosis, endemic, bejel (endemic syphilis), pinta, yaws, Trichomonas vaginalis, 128 Trichophyton concentricum, casuative agent of Tinea imbricata, 203 Trichophyton rubrum, casuative agent of Tinea corporis, 202 Trichophyton tonsurans, casuative agent of Tinea capitis, 203 Trichophyton violaceum, casuative agent of Tinea capitis, 203 Tropical dermatology, 151 Tropical rickettsioses, Tropical superficial mycoses, 202 Tropics, allergic skin reactions in, allergic blistering reactions, pemphigus foliaceus and erythematosus, Tropics, allergic skin reactions in allergic conditions, other lichen planus, lichen planus actinicus, 164 urticaria, 164 benign chronic bullous dermatosis of childhood, 163 dermatitis herpetiformis, 163 drug eruptions erythema multiforme, 165 erythema nodosum, 166 fixed, toxic epidermal necrolysis, eczematous dermatitis and related conditions airborne contact dermatitis, 161 atopic dermatitis, contact dermatitis, 161 infantile acropustulosis, 161 papular urticaria, pompholyx, 160 photoallergic dermatitis and phytophotodermatitis, 161 podoconiosis, 161 Tumors, cutaneous, Ultraviolet-A1 phototherapy, for cutaneous LE, Urticaria, 116 allergic condition in tropics, 164 Urticaria pigmentosa (UP), 312 Vaccination, smallpox, Vagina and vulva, infectious diseases of bacterial vaginosis, candidal vulvovaginitis, 127 herpes simplex virus (HSV), human papillomavirus, 128 trichomonas vaginalis, 128 Vaginal and vulvar physiology of pregnancy, Varicose and spider veins secondary to pregnancy, 138 Variola minor, 155

11 e11 Vascular lesions facial telangiectases, hemangioma, 12 laser treatment of, 8-14 leg veins, photodynamic therapy, 14 port-wine stain, 12 Vasopressin, Venoms, spider, 215 Vitiligo and psoriasis, 308-nm excimer laser for, Vulva, effects of pregnancy on, 126. See also Vagina glandular diseases, 127 WHO global smallpox eradication program, 155 Wolbachia, target for antibiotic therapy for onchocerciasis, 179 Yaws, endemic treponematosis, Yeast(s) infections, 202 infections in HIV/AIDS patients, 208 Penicillium marneffei, Yellow skin (carotenodermia), 240 Zygomycosis,